Reports and Data

Downstream Processing Market Research Report Including SWOT Analysis, PESTELE Analysis, Drivers, Restraints, Global Industry Outlook and Key Players Analysis by 2027

The significant rise in demand for recombinant and the exponential expansion of the biotechnology industry are driving the demand for the market.


New York, NY -- (SBWIRE) -- 05/04/2021 -- Downstream Processing Market Size – USD 18.22 Billion in 2019, Industry Growth - CAGR of 12.7%, Industry Trends –rising investment from biotechnology companies for research and development.

The global Downstream Processing Market is forecasted to reach USD 45.49 Billion by 2027, according to a new report by Reports and Data. Over the forecast timeline due to the rising demand for biopharmaceuticals, the market for Downstream Processing will grow substantially. Besides, in the forecasted timeframe, the biotechnology sector's rapid growth is likely to accelerate business growth further. Downstream processing provides an important function in order to produce a healthy, clean, and affordable platform for any bio-project.

The rising prevalence of transmissible disorders like influenza, hepatitis, swine flu, etc. The demand for effective antibodies for such fatal diseases has grown, leading to a rise in the growth of the global downstream processing market. Besides, the rise in the investment for research and development activities from several biotechnology companies is likely to further stimulate the market growth over the forecasted timeline.

Request a Sample Copy of the Research Report @

Leading Players Profiled in the Report Include:

GE Healthcare, Danaher Corporation, Sartorius Stedim Biotech S.A., Merck KGaA, 3M, Lonza Group AG, Repligen Corporation, Eppendorf AG, Thermo Fisher Scientific Inc., and Corning Incorporated, among others.

The COVID-19 impact:

The distribution of Covid-19's has influenced industrial activities worldwide. Over the weeks, the market has experienced a downturn that can continue in the coming months. The virus led to the implementation of lockdown, which disrupted the workings of the asset management program as the healthcare sector witnessed a collapse in several countries. They were loaded with patients infected by a coronavirus. Millions of people were infected, and thousands of them died, including the healthcare staff. Although the market suffered a major setback at the time, the industry is bouncing back as there is a greater need for better management and upgrading the medical sector.

Further key findings from the report suggest

The market is expected to be dominated by the Purifying by Chromatography segment, and the segment is anticipated to rise with a CAGR of 12.8% in the forecasted timeframe. The essential component of a chromatography method is the columns and resins, which are commonly used during the isolation, retrieval, and purification of bioactive components of the sample. It is expected that the continuous demand for new and diverse varieties of columns and resins will drive the growth of the segment.

The vaccinations segment is likely to hold the largest market over the forecasted period. The expansion of this segment is anticipated to be driven by technical advances in downstream purification technology to produce elevated vaccines at lower prices.

The Asia Pacific is anticipated to experience the fastest growth in the downstream processing market, owing to growing biotechnology funding by suppliers and clients. The downstream processing market in the region is also spurred by growing demand for biopharmaceuticals and rising R&D activities in the biopharmaceutical industry.

Get Attractive Discount @

For the purpose of this report, Reports and Data has segmented into the Global Downstream Processing Market on the basis of product, method, application, end-user, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)


Method Outlook (Revenue, USD Billion; 2017-2027)

Purifying by Chromatography
Disruption of Cells

Membrane filtration
Solid-liquid Separation

Application Outlook (Revenue, USD Billion; 2017-2027)

Enzyme Synthesis
Production of Hormones
Producing antibodies
Development of Antibiotics
Making Vaccinations

End-User Outlook (Revenue, USD Billion; 2017-2027)

Contract Manufacturing Organizations
Biopharmaceutical Manufacturers

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America
Rest of Europe
Asia Pacific
South Korea
Rest of APAC
Saudi Arabia
Rest of MEA
Latin America
Rest of LATAM

Request for Customization @

Table of contents           

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Downstream Processing Market Segmentation & Impact Analysis

    4.1. Downstream Processing Market Material Segmentation Analysis

    4.2. Industrial Outlook

           4.2.1. Market indicators analysis

           4.2.2. Market drivers analysis

           The significant rise in demand for recombinant and drug-quality

           The increase in biologic infiltration and biological macromolecules

           The exponential expansion of the biotechnology industry

           Growing demand for biopharmaceuticals

           4.2.3. Market restraints analysis

           The high cost of instruments

            Lack of single-use options and purification bottlenecks

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. ETOP Analysis

    4.6. Porter's Five Forces Analysis

    4.7. Competitive Metric Space Analysis

    4.8. Price trend Analysis

    4.9. Customer Mapping

    4.10. Covid-19 Impact Analysis

    4.11. Global Recession Influence


Have Any Query? Ask Our Experts @

Thank you for reading our report. In case of further queries regarding the report or inquiry about its customization, please connect with us. We will ensure your report is well-suited to your requirements.

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.